Dr. Reddy's Laboratories Results Earnings Call for Q4FY23
Conference Call with Dr. Reddy's Laboratories Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.10-05-2023
Dr. Reddy's Laboratories Results Earnings Call for Q4FY23
Conference Call with Dr. Reddy's Laboratories Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023
Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the applicable disclosure on related party transactions for the half year ended March 31, 2023, in the requisite format.DR.REDDY'S LABORATORIES LTD. - 500124 - Book Closure For Dividend And Annual General Meeting Scheduled On Thursday, July 27, 2023.
39th Annual General Meeting (AGM) of the members of the Company scheduled to be held on Thursday, July 27, 2023. The Register of Members and the Share Transfer Books of the Company shall remain closed from Wednesday, July 12, 2023, to Friday, July 14, 2023 (both days inclusive) for the purpose of the Dividend and Annual General Meeting of the Company.DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Change in Directorate
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.DR.REDDY'S LABORATORIES LTD. - 500124 - Audited Financial Results For FY23
Audited Financial Results for FY23DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Audited Financial Results of FY23DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Dividend Updates
Recommendation of final dividend for the financial year 2022-23.DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 10, 2023 - Audited Financial Results And Recommendation Of Dividend For FY23
Outcome of Board Meeting held on May 10, 2023 - Audited Financial Results and recommendation of Dividend for FY23DR.REDDY'S LABORATORIES LTD. - 500124 - Grant Of Employee Stock Options
Grant of employee stock options